APO Research
Talk to an analyst

APO RESEARCH · REPORT

Levosulpiride

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Levosulpiride Market Outlook and Growth Opportunities 2026

21 December 2025198 pages

Choose your research edition.

Industry ResearchLevosulpiride Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Levosulpiride Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Levosulpiride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Levosulpiride Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Levosulpiride Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Levosulpiride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Levosulpiride market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Levosulpiride market include Sun Pharmaceutical Industries, Suzhou Chenghe Pharmaceutical & Chemical, Harbin Gloria Pharmaceuticals, Vasoya Industries, New Donghai Pharmaceutical and Bona Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Levosulpiride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Levosulpiride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Levosulpiride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Levosulpiride market size, projected growth trends, production technologies, key applications, and end-use industries.

Levosulpiride Segment by Company

Sun Pharmaceutical Industries

Suzhou Chenghe Pharmaceutical & Chemical

Harbin Gloria Pharmaceuticals

Vasoya Industries

New Donghai Pharmaceutical

Bona Chemical

Levosulpiride Segment by Type

Above 98%

Below 98%

Levosulpiride Segment by Application

Tablet

Capsule

Other

Levosulpiride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Levosulpiride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Levosulpiride market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Levosulpiride significant trends, drivers, influence factors in global and regions.

6. To analyze Levosulpiride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levosulpiride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Levosulpiride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levosulpiride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Levosulpiride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Levosulpiride industry.

Chapter 3: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Levosulpiride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Levosulpiride in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Levosulpiride Industry Trends Table 2. Levosulpiride Industry Drivers Table 3. Levosulpiride Industry Opportunities and Challenges Table 4. Levosulpiride Industry Restraints Table 5. Global Levosulpiride Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Levosulpiride Revenue Share by Company (2021-2026) Table 7. Global Levosulpiride Sales Volume by Company (kg) & (2021-2026) Table 8. Global Levosulpiride Sales Volume Share by Company (2021-2026) Table 9. Global Levosulpiride Average Price (US$/kg) of Company (2021-2026) Table 10. Global Levosulpiride Company Ranking, (2024-2026) & (USD Million) Table 11. Global Levosulpiride Key Company Manufacturing Base & Headquarters Table 12. Global Levosulpiride Company, Product Type & Application Table 13. Global Levosulpiride Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Levosulpiride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Above 98% Table 18. Significant Companies of Below 98% Table 19. Global Levosulpiride Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Levosulpiride Sales Volume by Type (2021-2026) & (kg) Table 21. Global Levosulpiride Sales Volume by Type (2027-2032) & (kg) Table 22. Global Levosulpiride Sales Volume Share by Type (2021-2026) Table 23. Global Levosulpiride Sales Volume Share by Type (2027-2032) Table 24. Global Levosulpiride Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Levosulpiride Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Levosulpiride Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Levosulpiride Sales Value Share by Type (2021-2026) Table 28. Global Levosulpiride Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tablet Table 30. Significant Companies of Capsule Table 31. Significant Companies of Other Table 32. Global Levosulpiride Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Levosulpiride Sales Volume by Application (2021-2026) & (kg) Table 34. Global Levosulpiride Sales Volume by Application (2027-2032) & (kg) Table 35. Global Levosulpiride Sales Volume Share by Application (2021-2026) Table 36. Global Levosulpiride Sales Volume Share by Application (2027-2032) Table 37. Global Levosulpiride Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Levosulpiride Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Levosulpiride Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Levosulpiride Sales Value Share by Application (2021-2026) Table 41. Global Levosulpiride Sales Value Share by Application (2027-2032) Table 42. Global Levosulpiride Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Levosulpiride Sales by Region (2021-2026) & (kg) Table 44. Global Levosulpiride Sales Market Share by Region (2021-2026) Table 45. Global Levosulpiride Sales by Region (2027-2032) & (kg) Table 46. Global Levosulpiride Sales Market Share by Region (2027-2032) Table 47. Global Levosulpiride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Levosulpiride Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Levosulpiride Sales Value Share by Region (2021-2026) Table 50. Global Levosulpiride Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Levosulpiride Sales Value Share by Region (2027-2032) Table 52. Global Levosulpiride Market Average Price (US$/kg) by Region (2021-2026) Table 53. Global Levosulpiride Market Average Price (US$/kg) by Region (2027-2032) Table 54. Global Levosulpiride Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Global Levosulpiride Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Levosulpiride Sales by Country (2021-2026) & (kg) Table 57. Global Levosulpiride Sales Market Share by Country (2021-2026) Table 58. Global Levosulpiride Sales by Country (2027-2032) & (kg) Table 59. Global Levosulpiride Sales Market Share by Country (2027-2032) Table 60. Global Levosulpiride Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Levosulpiride Sales Value Market Share by Country (2021-2026) Table 62. Global Levosulpiride Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Levosulpiride Sales Value Market Share by Country (2027-2032) Table 64. Sun Pharmaceutical Industries Company Information Table 65. Sun Pharmaceutical Industries Business Overview Table 66. Sun Pharmaceutical Industries Levosulpiride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Sun Pharmaceutical Industries Levosulpiride Product Portfolio Table 68. Sun Pharmaceutical Industries Recent Development Table 69. Suzhou Chenghe Pharmaceutical & Chemical Company Information Table 70. Suzhou Chenghe Pharmaceutical & Chemical Business Overview Table 71. Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio Table 73. Suzhou Chenghe Pharmaceutical & Chemical Recent Development Table 74. Harbin Gloria Pharmaceuticals Company Information Table 75. Harbin Gloria Pharmaceuticals Business Overview Table 76. Harbin Gloria Pharmaceuticals Levosulpiride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio Table 78. Harbin Gloria Pharmaceuticals Recent Development Table 79. Vasoya Industries Company Information Table 80. Vasoya Industries Business Overview Table 81. Vasoya Industries Levosulpiride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Vasoya Industries Levosulpiride Product Portfolio Table 83. Vasoya Industries Recent Development Table 84. New Donghai Pharmaceutical Company Information Table 85. New Donghai Pharmaceutical Business Overview Table 86. New Donghai Pharmaceutical Levosulpiride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. New Donghai Pharmaceutical Levosulpiride Product Portfolio Table 88. New Donghai Pharmaceutical Recent Development Table 89. Bona Chemical Company Information Table 90. Bona Chemical Business Overview Table 91. Bona Chemical Levosulpiride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Bona Chemical Levosulpiride Product Portfolio Table 93. Bona Chemical Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Levosulpiride Distributors List Table 97. Levosulpiride Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Levosulpiride Product Image Figure 2. Global Levosulpiride Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levosulpiride Sales Value (2021-2032) & (US$ Million) Figure 4. Global Levosulpiride Sales (2021-2032) & (kg) Figure 5. Global Levosulpiride Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Levosulpiride Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Above 98% Image Figure 10. Below 98% Image Figure 11. Global Levosulpiride Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Levosulpiride Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Levosulpiride Sales Volume Share by Type (2021-2032) Figure 14. Global Levosulpiride Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Levosulpiride Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Levosulpiride Sales Value Share by Type (2021-2032) Figure 17. Tablet Image Figure 18. Capsule Image Figure 19. Other Image Figure 20. Global Levosulpiride Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Levosulpiride Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Levosulpiride Sales Volume Share by Application (2021-2032) Figure 23. Global Levosulpiride Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Levosulpiride Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Levosulpiride Sales Value Share by Application (2021-2032) Figure 26. Global Levosulpiride Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 27. Global Levosulpiride Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Levosulpiride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Levosulpiride Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Levosulpiride Sales Value (2021-2032) & (US$ Million) Figure 31. North America Levosulpiride Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Levosulpiride Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Levosulpiride Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Levosulpiride Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Levosulpiride Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Levosulpiride Sales Value (2021-2032) & (US$ Million) Figure 37. South America Levosulpiride Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Levosulpiride Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Levosulpiride Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Levosulpiride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Levosulpiride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Levosulpiride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Levosulpiride Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Levosulpiride Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Above 98%
  • Below 98%
Applications
  • Tablet
  • Capsule
  • Other
Companies covered
  • Sun Pharmaceutical Industries
  • Suzhou Chenghe Pharmaceutical & Chemical
  • Harbin Gloria Pharmaceuticals
  • Vasoya Industries
  • New Donghai Pharmaceutical
  • Bona Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Levosulpiride Sales Value (2021-2032)
  4. 1.2.2 Global Levosulpiride Sales Volume (2021-2032)
  5. 1.2.3 Global Levosulpiride Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Levosulpiride Market Dynamics
  1. 2.1 Levosulpiride Industry Trends
  2. 2.2 Levosulpiride Industry Drivers
  3. 2.3 Levosulpiride Industry Opportunities and Challenges
  4. 2.4 Levosulpiride Industry Restraints
3 Levosulpiride Market by Company
  1. 3.1 Global Levosulpiride Company Revenue Ranking in 2025
  2. 3.2 Global Levosulpiride Revenue by Company (2021-2026)
  3. 3.3 Global Levosulpiride Sales Volume by Company (2021-2026)
  4. 3.4 Global Levosulpiride Average Price by Company (2021-2026)
  5. 3.5 Global Levosulpiride Company Ranking (2024-2026)
  6. 3.6 Global Levosulpiride Company Manufacturing Base and Headquarters
  7. 3.7 Global Levosulpiride Company Product Type and Application
  8. 3.8 Global Levosulpiride Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Levosulpiride Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Levosulpiride Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Levosulpiride Market by Type
  1. 4.1 Levosulpiride Type Introduction
  2. 4.1.1 Above 98%
  3. 4.1.2 Below 98%
  4. 4.2 Global Levosulpiride Sales Volume by Type
  5. 4.2.1 Global Levosulpiride Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Levosulpiride Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Levosulpiride Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Levosulpiride Sales Value by Type
  9. 4.3.1 Global Levosulpiride Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Levosulpiride Sales Value by Type (2021-2032)
  11. 4.3.3 Global Levosulpiride Sales Value Share by Type (2021-2032)
5 Levosulpiride Market by Application
  1. 5.1 Levosulpiride Application Introduction
  2. 5.1.1 Tablet
  3. 5.1.2 Capsule
  4. 5.1.3 Other
  5. 5.2 Global Levosulpiride Sales Volume by Application
  6. 5.2.1 Global Levosulpiride Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Levosulpiride Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Levosulpiride Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Levosulpiride Sales Value by Application
  10. 5.3.1 Global Levosulpiride Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Levosulpiride Sales Value by Application (2021-2032)
  12. 5.3.3 Global Levosulpiride Sales Value Share by Application (2021-2032)
6 Levosulpiride Regional Sales and Value Analysis
  1. 6.1 Global Levosulpiride Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Levosulpiride Sales by Region (2021-2032)
  3. 6.2.1 Global Levosulpiride Sales by Region: 2021-2026
  4. 6.2.2 Global Levosulpiride Sales by Region (2027-2032)
  5. 6.3 Global Levosulpiride Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Levosulpiride Sales Value by Region (2021-2032)
  7. 6.4.1 Global Levosulpiride Sales Value by Region: 2021-2026
  8. 6.4.2 Global Levosulpiride Sales Value by Region (2027-2032)
  9. 6.5 Global Levosulpiride Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Levosulpiride Sales Value (2021-2032)
  12. 6.6.2 North America Levosulpiride Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Levosulpiride Sales Value (2021-2032)
  15. 6.7.2 Europe Levosulpiride Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Levosulpiride Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Levosulpiride Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Levosulpiride Sales Value (2021-2032)
  21. 6.9.2 South America Levosulpiride Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Levosulpiride Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Levosulpiride Sales Value Share by Country, 2025 VS 2032
7 Levosulpiride Country-level Sales and Value Analysis
  1. 7.1 Global Levosulpiride Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Levosulpiride Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Levosulpiride Sales by Country (2021-2032)
  4. 7.3.1 Global Levosulpiride Sales by Country (2021-2026)
  5. 7.3.2 Global Levosulpiride Sales by Country (2027-2032)
  6. 7.4 Global Levosulpiride Sales Value by Country (2021-2032)
  7. 7.4.1 Global Levosulpiride Sales Value by Country (2021-2026)
  8. 7.4.2 Global Levosulpiride Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Levosulpiride Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Levosulpiride Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Levosulpiride Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Levosulpiride Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Levosulpiride Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Levosulpiride Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Levosulpiride Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Levosulpiride Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Levosulpiride Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Levosulpiride Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Levosulpiride Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Levosulpiride Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Levosulpiride Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Levosulpiride Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Levosulpiride Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Levosulpiride Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Levosulpiride Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Levosulpiride Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Levosulpiride Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Levosulpiride Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Levosulpiride Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Levosulpiride Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Levosulpiride Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Levosulpiride Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Levosulpiride Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Levosulpiride Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Levosulpiride Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Levosulpiride Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Levosulpiride Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Levosulpiride Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Levosulpiride Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Levosulpiride Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Levosulpiride Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Levosulpiride Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Levosulpiride Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Levosulpiride Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Levosulpiride Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Levosulpiride Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Levosulpiride Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Levosulpiride Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Levosulpiride Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Levosulpiride Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Levosulpiride Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Levosulpiride Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Levosulpiride Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Levosulpiride Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Levosulpiride Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Levosulpiride Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Levosulpiride Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Levosulpiride Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Levosulpiride Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Levosulpiride Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Levosulpiride Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Levosulpiride Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Levosulpiride Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Levosulpiride Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Levosulpiride Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Levosulpiride Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Levosulpiride Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Levosulpiride Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Levosulpiride Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Levosulpiride Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Levosulpiride Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Levosulpiride Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Levosulpiride Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Levosulpiride Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Levosulpiride Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Levosulpiride Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Levosulpiride Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Levosulpiride Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Levosulpiride Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Levosulpiride Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Levosulpiride Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Levosulpiride Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Levosulpiride Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Levosulpiride Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Levosulpiride Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Levosulpiride Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Levosulpiride Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Levosulpiride Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Levosulpiride Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Levosulpiride Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Levosulpiride Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Levosulpiride Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Levosulpiride Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Suzhou Chenghe Pharmaceutical & Chemical
  8. 8.2.1 Suzhou Chenghe Pharmaceutical & Chemical Company Information
  9. 8.2.2 Suzhou Chenghe Pharmaceutical & Chemical Business Overview
  10. 8.2.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio
  12. 8.2.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Developments
  13. 8.3 Harbin Gloria Pharmaceuticals
  14. 8.3.1 Harbin Gloria Pharmaceuticals Company Information
  15. 8.3.2 Harbin Gloria Pharmaceuticals Business Overview
  16. 8.3.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio
  18. 8.3.5 Harbin Gloria Pharmaceuticals Recent Developments
  19. 8.4 Vasoya Industries
  20. 8.4.1 Vasoya Industries Company Information
  21. 8.4.2 Vasoya Industries Business Overview
  22. 8.4.3 Vasoya Industries Levosulpiride Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vasoya Industries Levosulpiride Product Portfolio
  24. 8.4.5 Vasoya Industries Recent Developments
  25. 8.5 New Donghai Pharmaceutical
  26. 8.5.1 New Donghai Pharmaceutical Company Information
  27. 8.5.2 New Donghai Pharmaceutical Business Overview
  28. 8.5.3 New Donghai Pharmaceutical Levosulpiride Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 New Donghai Pharmaceutical Levosulpiride Product Portfolio
  30. 8.5.5 New Donghai Pharmaceutical Recent Developments
  31. 8.6 Bona Chemical
  32. 8.6.1 Bona Chemical Company Information
  33. 8.6.2 Bona Chemical Business Overview
  34. 8.6.3 Bona Chemical Levosulpiride Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bona Chemical Levosulpiride Product Portfolio
  36. 8.6.5 Bona Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Levosulpiride Value Chain Analysis
  2. 9.1.1 Levosulpiride Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Levosulpiride Sales Mode & Process
  6. 9.2 Levosulpiride Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Levosulpiride Distributors
  9. 9.2.3 Levosulpiride Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst